Can-Fite BioPharma Ltd.

AMEX: CANF · Real-Time Price · USD
0.66
-0.01 (-1.79%)
At close: Aug 15, 2025, 3:59 PM
0.65
-1.62%
After-hours: Aug 15, 2025, 07:19 PM EDT

Can-Fite BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-7.88M -7.63M -10.17M -12.62M
Depreciation & Amortization
7K 15K 14K 14K
Stock-Based Compensation
362K 261K 263K 466K
Other Working Capital
-458K -474K -1.24M 2.09M
Other Non-Cash Items
141K -139K 396K -46K
Deferred Income Tax
n/a n/a n/a -94K
Change in Working Capital
-267K -943K -1.3M 2.48M
Operating Cash Flow
-7.64M -8.44M -10.8M -9.86M
Capital Expenditures
-5K -2K -9K -11K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -14.5M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
1.5M 500K 9.51M -14.5M
Investing Cash Flow
1.5M 498K 9.5M -14.51M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
6.71M 9.14M n/a 20.46M
Net Cash Flow
547K 1.3M -1.41M -3.88M
Free Cash Flow
-7.64M -8.44M -10.81M -9.87M